Effect of a new aldose reductase inhibit
β
R. Kikkawa; I. Hatanaka; H. Yasuda; N. Kobayashi; Y. Shigeta; H. Terashima; T. M
π
Article
π
1983
π
Springer
π
English
β 270 KB
A new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) was administered orally to streptozotocin-diabetic rats (60 mg/kg IV) for 14 days and its effect on motor nerve conduction velocity studied. The compound significantly improved motor nerve